Inari Medical to Announce Third Quarter 2024 Financial Results
Inari Medical (NASDAQ: NARI) has announced it will release its third quarter 2024 financial results on Monday, October 28, 2024. The company, which focuses on treating venous and other diseases, will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results and recent highlights.
Interested parties can access the earnings call via telephone or webinar. The call-in numbers are 844-825-9789 for domestic callers and 412-317-5180 for international callers. The webinar can be accessed through Inari's investor relations website or by registering online. A replay of the webinar will be available shortly after the call and archived on Inari's website.
Inari Medical (NASDAQ: NARI) ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 lunedì 28 ottobre 2024. L'azienda, che si concentra sul trattamento delle malattie venose e di altre malattie, ospiterà una conferenza telefonica e un webcast alle 1:30 p.m. ora del Pacifico / 4:30 p.m. ora dell'Est per discutere i risultati e i recenti traguardi.
Le parti interessate possono accedere alla chiamata sugli utili tramite telefono o webinar. I numeri per la chiamata sono 844-825-9789 per i chiamanti nazionali e 412-317-5180 per i chiamanti internazionali. Il webinar può essere accessibile tramite il sito web per gli investitori di Inari o registrandosi online. Una registrazione del webinar sarà disponibile poco dopo la chiamata e sarà archiviata sul sito web di Inari.
Inari Medical (NASDAQ: NARI) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el lunes 28 de octubre de 2024. La empresa, que se centra en el tratamiento de enfermedades venosas y otras enfermedades, llevará a cabo una conferencia telefónica y un webcast a las 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este para discutir los resultados y los logros recientes.
Las partes interesadas pueden acceder a la llamada de resultados a través del teléfono o del webinar. Los números de llamada son 844-825-9789 para los que llaman desde el país y 412-317-5180 para los que llaman desde el extranjero. El webinar se puede acceder a través del sitio web de relaciones con inversores de Inari o registrándose en línea. Una grabación del webinar estará disponible poco después de la llamada y se archiverá en el sitio web de Inari.
Inari Medical (NASDAQ: NARI)가 2024년 3분기 재무 결과를 2024년 10월 28일 월요일에 발표한다고 발표했습니다. 정맥 및 기타 질병 치료에 중점을 둔 이 회사는 태평양 시간 오후 1시 30분 / 동부 시간 오후 4시 30분에 결과 및 최근 주요 사항에 대해 논의하기 위해 컨퍼런스 콜 및 웹캐스트를 주최합니다.
관심 있는 분들은 전화 또는 웨비나를 통해 실적 발표에 접근할 수 있습니다. 전화로 연결하는 숫자는 국내 이용자에게는 844-825-9789, 국제 이용자에게는 412-317-5180입니다. 웨비나는 Inari의 투자자 관계 웹사이트를 통해 접근하거나 온라인 등록을 통해 참여할 수 있습니다. 콜 후 웹세미나의 재생이 곧 제공되며 Inari의 웹사이트에도 아카이브됩니다.
Inari Medical (NASDAQ: NARI) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le lundi 28 octobre 2024. L'entreprise, qui se concentre sur le traitement des maladies veineuses et d'autres maladies, organisera une conférence téléphonique et un webinaire à 13h30 heure du Pacifique / 16h30 heure de l'Est pour discuter des résultats et des points forts récents.
Les parties intéressées peuvent accéder à la conférence téléphonique via téléphone ou webinaire. Les numéros d'appel sont 844-825-9789 pour les appelants nationaux et 412-317-5180 pour les appelants internationaux. Le webinaire peut être accessible à travers le site web des relations avec les investisseurs d'Inari ou en s'inscrivant en ligne. Un replay du webinaire sera disponible peu après l'appel et sera archivé sur le site d'Inari.
Inari Medical (NASDAQ: NARI) hat bekannt gegeben, dass sie ihre Finanzergebnisse für das dritte Quartal 2024 am Montag, den 28. Oktober 2024 veröffentlichen wird. Das Unternehmen, das sich auf die Behandlung von venösen und anderen Erkrankungen konzentriert, wird um 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse und aktuelle Highlights zu besprechen.
Interessierte Parteien können die Ergebnisbesprechung telefonisch oder über das Webinar erreichen. Die Einwahlnummern sind 844-825-9789 für nationale Anrufer und 412-317-5180 für internationale Anrufer. Das Webinar kann über die Investorenbeziehungswebsite von Inari oder durch Online-Registrierung aufgerufen werden. Eine Wiederholung des Webinars wird kurz nach dem Anruf verfügbar sein und auf der Website von Inari archiviert.
- None.
- None.
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its third quarter 2024 financial results on Monday, October 28, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers. The live webinar may be accessed by visiting the Events Section of the Inari investor relations website or by registering here. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Inari’s website.
About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous disease, including venous thromboembolism, chronic venous disease and beyond. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn, X (Twitter), and Instagram.
Investor Contact:
Marissa Bych
Gilmartin Group LLC
IR@inarimedical.com
FAQ
When will Inari Medical (NARI) release its Q3 2024 financial results?
What time is Inari Medical's (NARI) Q3 2024 earnings call scheduled for?
How can investors access Inari Medical's (NARI) Q3 2024 earnings call?
Will there be a replay available for Inari Medical's (NARI) Q3 2024 earnings call?
